- Featured News /
Seeking to evolve the way it educates and engages with healthcare professionals, Novartis is using digital technology to enhance the quality, transparency and reach of its interactions with the medical community.
- Featured News /
Jay Bradner, President of the Novartis Institutes for BioMedical Research (NIBR) and Vas Narasimhan, Head of Global Drug Development and Chief Medical Officer, share their outlook for innovation in 2017.
- Featured News /
We’re honoring World Cancer Day with a new series called “Let’s Talk About the C Word: From Cancer to Cures” to address challenging conversations on cancer.
- Featured News /
Five virtual power purchase agreements with three developers expected to add more than 275 megawatts of clean power to the electrical grid.
- Statement /
Novartis has appointed Marc Boutin as Global Head of Patient Engagement & Advocacy. He will join Novartis no later than November 1, 2020.
- Statement /
Form 483 posting by US Food and Drug Administration (FDA) – Novartis statement
- Featured News /
Over 1,800 delegates came together at the annual Co-Creating Impact Summit to explore how understanding ‘impact’ is a crucial step in ensuring business makes a positive contribution to the world.
- Featured News /
Results of the Sickle Cell World Assessment Survey (SWAY) highlight the impact this debilitating disease has on patients and their families.
- Featured News /
Patient community representatives call for improved digital health literacy, standardised digital platforms, and co-creation of digital solutions.
- Featured News /
Novartis maintained its position in the 2021 Access to Medicine Index, leading in its approach to product delivery, while performing strongly across all other areas of the Index.
Pagination
- ‹ Previous page
- 1
- …
- 99
- 100
- 101
- 102
- 103
- 104
- 105
- …
- 277
- › Next page